Topic Highlight
Copyright ©2007 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Sep 28, 2007; 13(36): 4824-4830
Published online Sep 28, 2007. doi: 10.3748/wjg.v13.i36.4824
Neutralizing antibodies in hepatitis C virus infection
Mirjam B Zeisel, Samira Fafi-Kremer, Isabel Fofana, Heidi Barth, Françoise Stoll-Keller, Michel Doffoël, Thomas F Baumert
Mirjam B Zeisel, Samira Fafi-Kremer, Isabel Fofana, Françoise Stoll-Keller, Thomas F Baumert, Inserm, U748, Strasbourg, France
Mirjam B Zeisel, Samira Fafi-Kremer, Isabel Fofana, Françoise Stoll-Keller, Michel Doffoël, Thomas F Baumert, Université Louis Pasteur, Strasbourg, France
Michel Doffoël, Thomas F Baumert, Service d’Hépatogastro-entérologie, Hôpitaux Universitaires de Strasbourg; Strasbourg, France
Heidi Barth, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States
Author contributions: All authors contributed equally to the work.
Supported by Inserm, France; Université Louis Pasteur, France; the European Union (Virgil Network of Excellence); the Deutsche Forschungsgemeinschaft (Ba1417/11-1), Germany; the ANR chair of excellence program and ANRS, France; Inserm “Poste Vert” research fellowship in the framework of Inserm European Associated Laboratory Inserm U748-Department of Medicine II, University of Freiburg, Germany
Correspondence to: Thomas F Baumert, MD, Inserm Unité 748, Université Louis Pasteur, 3 Rue Koeberlé, Strasbourg F-67000, France. thomas.baumert@viro-ulp.u-strasbg.fr
Telephone: +33-390-243702 Fax: +33-390-243723
Received: June 26, 2007
Revised: July 2, 2007
Accepted: July 9, 2007
Published online: September 28, 2007
Core Tip